Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Study of Response-guided Neoadjuvant Sacituzumab Govitecan (IMMU-132) in Patients With Localized Triple-Negative Breast Cancer (NeoSTAR)
This research study is studying to evaluate sacituzumab govitecan for individuals with localized triple negative breast cancer (TNBC) The names of the study d…
Invasive Breast CancerTriple Negative Breast CancerER-Negative Breast Cancer+2 more
Estimated
~$10 – $6,250
Massachusetts General HospitalNCT04230109
Phase 2
DATO-BASE: A Phase 2 Trial of DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast cancer that h…
Breast CancerBreast Cancer FemaleMetastatic Triple-Negative Breast Carcinoma+4 more
Estimated
~$10 – $7,500
Sarah Sammons, MDNCT06176261